431 related articles for article (PubMed ID: 24220047)
1. Monitoring and long-term outcomes in vascularized composite allotransplantation.
Kaufman CL; Ouseph R; Marvin MR; Manon-Matos Y; Blair B; Kutz JE
Curr Opin Organ Transplant; 2013 Dec; 18(6):652-8. PubMed ID: 24220047
[TBL] [Abstract][Full Text] [Related]
2. Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration.
Kueckelhaus M; Fischer S; Seyda M; Bueno EM; Aycart MA; Alhefzi M; ElKhal A; Pomahac B; Tullius SG
Transpl Int; 2016 Jun; 29(6):655-62. PubMed ID: 26265179
[TBL] [Abstract][Full Text] [Related]
3. Vascularized composite allografts and solid organ transplants: similarities and differences.
Weissenbacher A; Hautz T; Pratschke J; Schneeberger S
Curr Opin Organ Transplant; 2013 Dec; 18(6):640-4. PubMed ID: 24126807
[TBL] [Abstract][Full Text] [Related]
4. Upper extremity and craniofacial vascularized composite allotransplantation: ethics and immunosuppression.
Benedict J; Magill G
Emerg Top Life Sci; 2019 Nov; 3(6):681-686. PubMed ID: 32915212
[TBL] [Abstract][Full Text] [Related]
5. Vascularized composite allotransplantation: towards tolerance and the importance of skin-specific immunobiology.
Leonard DA; Kurtz JM; Cetrulo CL
Curr Opin Organ Transplant; 2013 Dec; 18(6):645-51. PubMed ID: 24126805
[TBL] [Abstract][Full Text] [Related]
6. Vascularized composite allotransplantation versus solid organ transplantation: innate-adaptive immune interphase.
Kadono K; Gruszynski M; Azari K; Kupiec-Weglinski JW
Curr Opin Organ Transplant; 2019 Dec; 24(6):714-720. PubMed ID: 31577596
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of rejection in vascular composite allotransplantation.
Etra JW; Raimondi G; Brandacher G
Curr Opin Organ Transplant; 2018 Feb; 23(1):28-33. PubMed ID: 29189293
[TBL] [Abstract][Full Text] [Related]
8. Immunobiology in VCA.
Kaufman CL; Marvin MR; Chilton PM; Hoying JB; Williams SK; Tien H; Ozyurekoglu T; Ouseph R
Transpl Int; 2016 Jun; 29(6):644-54. PubMed ID: 26924305
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppression maintenance in vascularized composite allotransplantation: what is just right?
Howsare M; Jones CM; Ramirez AM
Curr Opin Organ Transplant; 2017 Oct; 22(5):463-469. PubMed ID: 28759463
[TBL] [Abstract][Full Text] [Related]
10. The role of B cell immunity in VCA graft rejection and acceptance.
Kaufman CL; Cascalho M; Ozyurekoglu T; Jones CM; Ramirez A; Roberts T; Tien HY; Moreno R; Galvis E; Tsai TM; Palazzo M; Farner S; Platt JL
Hum Immunol; 2019 Jun; 80(6):385-392. PubMed ID: 30836129
[TBL] [Abstract][Full Text] [Related]
11. Vascularized composite allograft-specific characteristics of immune responses.
Issa F
Transpl Int; 2016 Jun; 29(6):672-81. PubMed ID: 26927941
[TBL] [Abstract][Full Text] [Related]
12. Premise and promise of mesenchymal stem cell-based therapies in clinical vascularized composite allotransplantation.
Schweizer R; Gorantla VS; Plock JA
Curr Opin Organ Transplant; 2015 Dec; 20(6):608-14. PubMed ID: 26536421
[TBL] [Abstract][Full Text] [Related]
13. Chronic Rejection in Human Vascularized Composite Allotransplantation (Hand and Face Recipients): An Update.
Kanitakis J; Petruzzo P; Badet L; Gazarian A; Thaunat O; Testelin S; Devauchelle B; Dubernard JM; Morelon E
Transplantation; 2016 Oct; 100(10):2053-61. PubMed ID: 27163543
[TBL] [Abstract][Full Text] [Related]
14. Acute rejection in vascularized composite allotransplantation.
Fischer S; Lian CG; Kueckelhaus M; Strom TB; Edelman ER; Clark RA; Murphy GF; Chandraker AK; Riella LV; Tullius SG; Pomahac B
Curr Opin Organ Transplant; 2014 Dec; 19(6):531-44. PubMed ID: 25333831
[TBL] [Abstract][Full Text] [Related]
15. Sensitization and Desensitization in Vascularized Composite Allotransplantation.
Moris D; Cendales LC
Front Immunol; 2021; 12():682180. PubMed ID: 34456906
[TBL] [Abstract][Full Text] [Related]
16. Vascularised composite allotransplantation in solid organ transplant recipients: A systematic review.
Honeyman C; Stark HL; Fries CA; Gorantla VS; Davis MR; Giele H
J Plast Reconstr Aesthet Surg; 2021 Feb; 74(2):316-326. PubMed ID: 33036926
[TBL] [Abstract][Full Text] [Related]
17. Cellular activation pathways and interaction networks in vascularized composite allotransplantation.
Knoedler L; Knoedler S; Panayi AC; Lee CAA; Sadigh S; Huelsboemer L; Stoegner VA; Schroeter A; Kern B; Mookerjee V; Lian CG; Tullius SG; Murphy GF; Pomahac B; Kauke-Navarro M
Front Immunol; 2023; 14():1179355. PubMed ID: 37266446
[TBL] [Abstract][Full Text] [Related]
18. Chronic rejection in vascularized composite allografts.
Mundinger GS; Drachenberg CB
Curr Opin Organ Transplant; 2014 Jun; 19(3):309-14. PubMed ID: 24811439
[TBL] [Abstract][Full Text] [Related]
19. A Comparison of Immunosuppression Regimens in Hand, Face, and Kidney Transplantation.
Rifkin WJ; Manjunath AK; Kantar RS; Jacoby A; Kimberly LL; Gelb BE; Diaz-Siso JR; Rodriguez ED
J Surg Res; 2021 Feb; 258():17-22. PubMed ID: 32977237
[TBL] [Abstract][Full Text] [Related]
20. Costimulation Blockade in Vascularized Composite Allotransplantation.
Giannis D; Moris D; Cendales LC
Front Immunol; 2020; 11():544186. PubMed ID: 33042138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
